Which adults is Abrysvo indicated to protect against RSV-related lower respiratory tract disease?

Abrysvo is indicated to prevent RSV-related lower respiratory tract disease in adults aged 60 years and older and adults aged 18–59 years at increased risk of this disease, in accordance with official recommendations.